Work

Phase 3 randomized placebo-controlled trial of donepezil for cancer-related cognitive impairment among breast cancer survivors: Results on patient-reported cognitive function from the wake forest nCI community oncology research program (NCORP) research base REMEMBER trial (WF97116).

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.16_suppl.12076

Authors: Alayna E Ernster, Emily Van Meter Dressler, W. Mark Brown, Glenn Jay Lesser, William P. Fusselman, Vinay K. Gudena, Lynne I. Wagner, Heidi D. Klepin, Edward G. Shaw, Steve R. Rapp

Institutions: Wake Forest University Health Sciences, Wake Forest University, Physicians' Clinic of Iowa, Cone Health, Atrium Health Wake Forest Baptist

Language: English

Topic: Cancer-related cognitive impairment studies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W4379340894

Cites:

Cited by: 1

Related to: 10